熱門資訊> 正文
Ligand Pharmaceuticals首席运营官Matthew Korenberg即将离职
2024-08-03 05:53
- Ligand Pharmaceuticals (NASDAQ:LGND) announced that its President and Chief Operating Officer, Matthew Korenberg, will be departing from the company.
- Filing
More on Ligand Pharmaceuticals
- Ligand Pharmaceuticals: Solid Performer Performing Solidly
- Amgen, Garmin among relative market leaders poised to outperform in coming months: BTIG
- Ligand to buy APEIRON Biologics for $100M, ups 2024 revenue outlook
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。